1Mortensen L, Chines A, Myers WR, et al. Risedromae increases bone mass in an early postmenopausal populution: two years of treatment plus one year of follow. J Clin Endocrinol Metab, 1998,83:396-405.
2Fogelman I, Ribot C, Smith R, et al. Risedronate reverses bone loss in postmenopaual women with low bone mass: results from a mulhination, double-blind, placebo-controlled trial. J Clin Endocrinol Metab, 2000,85 : 1895-1900.